Adsorptive granulocyte and monocyte apheresis: A potentially relevant therapeutic option for COVID-19

The overproduction of proinflammatory cytokines and subsequent thromboembolism are major problems of coronavirus disease 2019 (COVID-19). Adsorptive granulocyte and monocyte apheresis (GMA), used for ulcerative colitis, is an extracorporeal therapy designed to remove activated myeloid lineage cells....

Descripción completa

Detalles Bibliográficos
Autores principales: Kanekura, Takuro, Kawahara, Koichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834290/
https://www.ncbi.nlm.nih.gov/pubmed/32721534
http://dx.doi.org/10.1016/j.ijid.2020.07.025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834290/
https://www.ncbi.nlm.nih.gov/pubmed/32721534
http://dx.doi.org/10.1016/j.ijid.2020.07.025

Ejemplares similares